What type of drug is fotantinib and its mechanism?

Fostamatinib (also known as Fostamatinib, English name: Fostamatinib) is an oral small molecule kinase inhibitor that belongs to the spleen tyrosine kinase (Syk) inhibitor class. It was originally developed by Rigel Pharmaceuticals and is currently on the market in many countries. It is mainly used to treat immune-related diseases such as chronic immune thrombocytopenia (ITP). The drug is a prodrug, which is converted into the active ingredient R406 after metabolism in the body, thereby exerting an inhibitory effect.

The core mechanism of action of fostatinib is to inhibit the Syk signaling pathway. Syk is an important tyrosine kinase expressed in B cells and certain immune cells. It plays a key role in regulating immune response, phagocytosis and antibody-mediated cytotoxicity. By inhibiting Syk, fostatinib blocks macrophage clearance of antibody-labeled platelets, thereby reducing platelet destruction and increasing peripheral platelet numbers.

Clinically, fostatinib is mainly used to treat adult patients with chronic immune thrombocytopenia who are refractory to first-line treatments such as corticosteroids or immunoglobulins. Compared with traditional immunosuppressants, fostatinib provides a new therapeutic approach by targeting specific cell signaling pathways to regulate the immune system rather than broadly suppressing immune function, thus reducing the risk of side effects caused by systemic immunosuppression to a certain extent.

In addition, fostatinib is also being studied for the treatment of rheumatoid arthritis, autoimmune hemolytic anemia and other diseases, showing certain potential. Despite this, you still need to be wary of some adverse reactions when using fostatinib, such as high blood pressure, elevated liver enzymes, diarrhea, etc. Therefore, it should be used under the guidance of a doctor, and blood pressure and liver function should be monitored regularly to ensure a balance between safety and efficacy.

Reference materials:https://www.drugs.com/